Bruce Langer, president, told Food Business News coming up with the functional beverage wasnt a big pivot for the 65-year-old company, because our DNA has always been around trying to be better-for-you in food and beverage. Today, with about one in eight adults taking GLP-1 drugs to lose weight or treat a chronic condition, the market opportunity for consumer packaged goods (CPG) manufacturers is growing, and Langers is responding
Retatrutide (not yet approved) - Find Medical Weight Loss Doctors Palm Desert, California We accept hundreds of insurance plans And many more
After 4 to 5 weeks of regular dosing, blood levels of semaglutide have reached steady state (this means they remain constant in the blood and dont fluctuate up and down)
Boehringer Ingelheim, the manufacturer, has advanced survodutide into Phase 3 trials for both obesity and metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
Nausea rates sit at 24%, vomiting at 13%, and diarrhea at 21%
Metabolic Shifts Retatrutide has been studied in adults with type 2 diabetes, but results from that research should not be compared casually with Ozempic or used to predict cardiovascular benefit